Title : The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients.

Pub. Date : 2015 Oct 20

PMID : 26384351






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cytotoxic effect was increased by decitabine through activation of p53 and inhibition of c-Myc, Survivin and Bcl-2. Decitabine BCL2 apoptosis regulator Homo sapiens